Literature DB >> 22555937

Tsukamurella sp. E105 as a new biocatalyst for highly enantioselective hydrolysis of ethyl 2-(2-oxopyrrolidin-1-yl) butyrate.

Junyao He1, Shuai Yuan, Pu Wang, Nengqiang Wang.   

Abstract

A new bacterial strain, E105, has been introduced as a biocatalyst for the enantioselective hydrolysis of ethyl (R,S)-2-(2-oxopyrrolidin-1-yl) butyrate, (R,S)-1, to (S)-2-(2-oxopyrrolidin-1-yl) butyric acid, (S)-2. This strain was isolated from 60 soil samples using (R,S)-1 as the sole carbon source. The isolate was identified as Tsukamurella tyrosinosolvens E105, based on its morphological characteristics, physiological tests, and 16S rDNA sequence analysis. The process of cell growth and hydrolase production for this strain was then investigated. The hydrolase activity reached its maximum after cultivation at 200 rpm and 30 °C for 36 h. Furthermore, the performance of the enantioselective hydrolysis of (R,S)-1 was studied. The optimal reaction temperature, initial pH, substrate concentration, and concentration of suspended cells were 30 °C, 6.8, 10 and 30 g/l (DCW), respectively. Under these conditions, a high conversion (>45 %) of the product (S)-2 with an excellent enantiomeric excess (ee) (>99 %), and a satisfied enantiomeric ratio (E) (>600) as well were obtained. This study showed that the bacterial isolate T. tyrosinosolvens E105 displayed a high enantioselectivity towards the hydrolysis of racemic ethyl 2-(2-oxopyrrolidin-1-yl) butyrate.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22555937     DOI: 10.1007/s10295-012-1132-y

Source DB:  PubMed          Journal:  J Ind Microbiol Biotechnol        ISSN: 1367-5435            Impact factor:   3.346


  16 in total

Review 1.  Biocatalysts for clean industrial products and processes.

Authors:  A T Bull; A W Bunch; G K Robinson
Journal:  Curr Opin Microbiol       Date:  1999-06       Impact factor: 7.934

Review 2.  Enzymatic and whole cell catalysis: finding new strategies for old processes.

Authors:  Carla C C R de Carvalho
Journal:  Biotechnol Adv       Date:  2010-09-15       Impact factor: 14.227

3.  Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate.

Authors:  Nathan B Fountain; Joan A Conry; Ildefonso Rodríguez-Leyva; Juvenal Gutierrez-Moctezuma; Edubijes Salas; René Coupez; Armel Stockis; Zhihong Sarah Lu
Journal:  Epilepsy Res       Date:  2007-01-31       Impact factor: 3.045

4.  Determination of levetiracetam in human plasma/serum/saliva by liquid chromatography-electrospray tandem mass spectrometry.

Authors:  Tiedong Guo; Lisa M Oswald; Damodara Rao Mendu; Steven J Soldin
Journal:  Clin Chim Acta       Date:  2006-06-27       Impact factor: 3.786

5.  Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: a pooled analysis of data from randomized clinical trials.

Authors:  Barry E Gidal; Eugène Baltès; Christian Otoul; Emilio Perucca
Journal:  Epilepsy Res       Date:  2005-04-08       Impact factor: 3.045

6.  Immobilization of Candida rugosa lipase on glass beads for enantioselective hydrolysis of racemic naproxen methyl ester.

Authors:  Elif Yilmaz; Keziban Can; Mehmet Sezgin; Mustafa Yilmaz
Journal:  Bioresour Technol       Date:  2010-08-26       Impact factor: 9.642

Review 7.  Levetiracetam: a review of its use in epilepsy.

Authors:  Katherine A Lyseng-Williamson
Journal:  Drugs       Date:  2011-03-05       Impact factor: 9.546

8.  Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.

Authors:  Petra M C Callenbach; Willem Frans M Arts; Robert ten Houten; Paul Augustijn; W Boudewijn Gunning; Els A J Peeters; Alma M Weber; Hans Stroink; Yvette Geerts; Ada T Geerts; Oebele F Brouwer
Journal:  Eur J Paediatr Neurol       Date:  2007-10-18       Impact factor: 3.140

9.  Clinical efficacy and cognitive and neuropsychological effects of levetiracetam in epilepsy: an open-label multicenter study.

Authors:  Tony Wu; Chih-Chuan Chen; Ta-Cheng Chen; Yuan-Fu Tseng; Chen-Bang Chiang; Chin-Chuan Hung; Horng-Huei Liou
Journal:  Epilepsy Behav       Date:  2009-09-26       Impact factor: 2.937

10.  Pharmacodynamic and pharmacokinetic interaction profiles of levetiracetam in combination with gabapentin, tiagabine and vigabatrin in the mouse pentylenetetrazole-induced seizure model: an isobolographic analysis.

Authors:  Monika Dudra-Jastrzebska; Marta M Andres-Mach; Marcin Sielski; Neville Ratnaraj; Philip N Patsalos; Stanislaw J Czuczwar; Jarogniew J Luszczki
Journal:  Eur J Pharmacol       Date:  2009-01-11       Impact factor: 4.432

View more
  1 in total

1.  Identification of a phosphorus-solubilizing Tsukamurella tyrosinosolvens strain and its effect on the bacterial diversity of the rhizosphere soil of peanuts growth-promoting.

Authors:  Hong Zhang; Lizhen Han; Biao Jiang; Changmei Long
Journal:  World J Microbiol Biotechnol       Date:  2021-05-31       Impact factor: 3.312

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.